Vuno announced its acquisition of shares in Coreline Soft for 3.4 billion KRW to enhance its chest imaging capabilities and focus on preventive medical AI solutions.

Target Company Information

Vuno, a medical artificial intelligence (AI) company, announced on the 12th of October its decision to acquire shares and equity certificates of Coreline Soft, a company specializing in chest imaging technologies, amounting to 3.4 billion KRW. This strategic acquisition is part of Vuno's broader goal to enhance its portfolio in medical AI, particularly in the field of imaging diagnostics.

As part of this transaction, Vuno is set to sign an asset transfer agreement with Coreline Soft to transfer technologies related to VUNO Med®-LungCT™ (hereafter referred to as LungCT). The majority of the payment for the shares will be funded by the revenues generated from this technology transfer.

Industry Overview

The medical AI sector in South Korea has witnessed significant growth in recent years, driven by substantial investments from both local and international firms. The government’s support for digital healthcare solutions, combined with